Senescent cells limit p53 activity via multiple mechanisms to remain viable

Area of Science:

• Cellular senescence
• Epigenetics
• Molecular biology

Background:

• Super-enhancers are crucial regulatory elements controlling cell type-specific gene expression.
• Senescence-associated super-enhancers are established in mouse embryonic fibroblasts, irrespective of the senescence trigger.
• These enhancers regulate genes involved in cell identity and function.

Purpose of the Study:

• To investigate the role of senescence-associated super-enhancer-regulated genes in the survival of senescent cells.
• To identify specific genes and mechanisms by which senescent cells evade apoptosis.
• To explore the translational potential of these findings for therapeutic interventions.

Main Methods:

• Gene knockdown experiments in senescent mouse embryonic fibroblasts.
• Analysis of core biological properties of senescent cells.
• Quantitative assessment of gene transcription (e.g., MDM2, RNASE4) in human senescent fibroblasts.

Main Results:

• A significant number of senescence-associated super-enhancer-regulated genes promote the survival of senescent cells.
• Mdm2, Rnase4, and Ang were identified as key mediators suppressing p53-induced apoptosis.
• Elevated MDM2 and RNASE4 transcription in human senescent cells restrains p53 and enhances survival.

Conclusions:

• Senescent cells employ specific super-enhancer-driven gene expression programs to promote survival.
• Mechanisms involving Mdm2, Rnase4, and Ang are critical for suppressing apoptosis in senescent cells.
• These findings offer molecular targets for developing senolytic therapies to eliminate senescent cells in pathological conditions.